drug class: antiinfectives
lamivudine
|
generic combivir lamivudine - zidovudine 150mg + 300mg get epivir with no prescription |
$1.44 per tablet 180 tablet |
Price: $260.00 |
|
|
generic combivir lamivudine - zidovudine 150mg + 300mg buy lamivudine - zidovudine with no prescription |
$1.58 per tablet 120 tablet |
Price: $190.00 |
|
|
generic combivir lamivudine - zidovudine 150mg + 300mg order epivir no prescription |
$1.67 per tablet 90 tablet |
Price: $150.00 |
|
|
generic epivir lamivudine 100mg buy lamivudine with no prescription |
$1.73 per tablet 180 tablet |
Price: $312.00 |
|
|
generic combivir lamivudine - zidovudine 150mg + 300mg purchase epivir without rx |
$1.83 per tablet 60 tablet |
Price: $110.00 |
|
|
generic epivir lamivudine 100mg order epivir no prescription |
$1.85 per tablet 120 tablet |
Price: $222.00 |
|
|
generic epivir lamivudine 150mg get epivir with no prescription |
$1.91 per tablet 180 tablet |
Price: $344.40 |
|
|
generic epivir lamivudine 100mg purchase epivir without rx |
$1.97 per tablet 90 tablet |
Price: $177.00 |
|
|
generic combivir lamivudine - zidovudine 150mg + 300mg order lamivudine - zidovudine without a prescription |
$2.00 per tablet 30 tablet |
Price: $60.00 |
|
|
generic epivir lamivudine 150mg lamivudine no prescription |
$2.15 per tablet 90 tablet |
Price: $193.20 |
|
|
generic epivir lamivudine 100mg order lamivudine without a prescription |
$2.20 per tablet 60 tablet |
Price: $132.00 |
|
|
generic epivir lamivudine 150mg buy epivir without a prescription |
$2.38 per tablet 60 tablet |
Price: $142.80 |
|
|
generic epivir lamivudine 150mg buy lamivudine with no prescription |
$3.08 per tablet 30 tablet |
Price: $92.40 |
it is also best known as epivir
products containing lamivudine:
3tc, zeffix, heptovir, epivir-hbv
3tc
it is also known as:| trade name | generic name |
| combivir | zidovudine 300mg & lamivudine 150mg tablets 6s |
| 3tc oral solution 10mg/ml | lamivudine 10 mg/ml oral solution (3tc) |
| zeffix oral solution 5mg/ml | lamivudine 5 mg/ml oral solution |
| zeffix tablet 100mg | lamivudine 100 mg tablet |
| 3tc tablets 150mg | lamivudine 150 mg tablet (3tc) |
| combivir tablet | zidovudine 300 mg tablet & lamivudine 150 mg tablet |
| trizivir tablets | zidovudine 300 mg tablet & lamivudine 150 mg tablet |
| kivexa tablets | lamivudine 300 mg& abacavir sulphate 600 mg tablet |
| sln 30 tablet | stavudine 30mg & lamivudine 150mg & nevirapine 200mg tablet (sln 30 tablet) |
| sln 40 tablet | stavudine 40mg & lamivudine 150mg & nevirapine 200mg tablet |
-
we offer you a convenient way to compare epivir prices from the various online pharmacies, and then shop at the one you feel presents the best value! we have the best prices for epivir to make shopping easier for you.
it will give you a epivir generic names, lamivudine trade names and many other good details about generic lamivudine.
best lamivudine prices getting a high position on the our listing and you can buy epivir or lamivudine online without a prescription at the best prices.
-
Japanese women will soon have a new contraceptive option. Japan's regulatory body, Koseisho, has approved the female condom for marketing and distribution in Japan. Approval came after a four-year development program, which included clinical trials conducted at 10 different centers. It is anticipated that the device, to be sold under the name Myfemy, will become available during the first six months of 2000.
Results of the Japanese study, published in the January 1998 issue of "Contraception," showed that the female condom is more than 97 percent effective when used consistently and correctly. U.S. based studies showed a 95 percent efficacy rate when used under similar conditions. In-vitro studies have demonstrated that it also provides significant protection from STD's, including HIV/AIDS. Its efficacy rates are comparable to those for the male condom and diaphragm, and it had a significantly lower failure rate than the cervical cap. Analysis from the Japanese clinical trial also showed that the female condom has an overall acceptability rating of 89 percent.
Clinical trials have been conducted all over the world, and the female condom first became available in 1992. It was approved for use in the United States in 1993.
The female condom is manufactured from polyurethane, a sturdy material that is unlikely to tear during use or cause an allergic reaction. Compared with the male condom, it has a longer shelf life, is resistant to the adverse effects of heat and humidity, and is overall more durable.
Traditionally, Japanese women have had limited access to contraceptive options, which makes the approval of a new device a very significant development. Oral contraceptives have only recently become available, and for the most part, they have relied on barrier methods. The male condom is the most common method employed, used by an estimated 85 percent of all couples seeking to avoid an unintended pregnancy. Interestingly enough, the majority of condoms are purchased by women.